Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 05/31 05:35:04 pm
1445 GBp   -0.52%
05/27DJGLAXOSMITHKLINE : Says European Commission Approves Stem-Cell Therap..
05/27 GLAXOSMITHKLINE : StrimvelisTM receives European marketing authorisa..
05/27 GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Mark..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline plc : Director/PDMR Shareholding

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/03/2012 | 08:11pm CEST

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of a Person Discharging Managerial Responsibility in the Ordinary Shares of GlaxoSmithKline plc ("Ordinary Shares") on 2 May 2012:

Mr S M Bicknell

Transfer of 250 Ordinary Shares into an ISA at £14.3225 per share.



The Company and the above mentioned person was advised of this transaction on 3 May 2012.

This notification relates to a transaction notified in accordance with Disclosure Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

3 May 2012


This information is provided by RNS
The company news service from the London Stock Exchange
ENDRDSQXLFBLEFXBBD
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
05/27DJGLAXOSMITHKLINE : Says European Commission Approves Stem-Cell Therapy
05/27 GLAXOSMITHKLINE : StrimvelisTM receives European marketing authorisation to trea..
05/27 GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Marketing Author..
05/27 GLAXOSMITHKLINE : Strimvelis receives EC marketing authorisation
05/27 GLAXOSMITHKLINE : Board and Committee changes
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against a Late-Stage..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26 GLAXOSMITHKLINE PAKISTAN : Dispatch of final dividend warrants of GlaxoSmithKlin..
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against Starting Lat..
05/25 INNOVIVA : Salford Lung Study results show COPD patients treated with Relvar® E..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials